BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 29
• 30
• 31

• Policy

  FDA Advisers Reject Regeneron Pharmaceuticals, Inc. Gout Drug

  May 9, 2012

   · 

  4 min read
• Pharm Country

  Novo Energies Corporation Announces New Name Change to Immunovative Therapies, Ltd. and New Trading Symbol

  May 9, 2012

   · 

  4 min read
• FDA

  St. Jude Medical Announces FDA Approval of Smaller ICD with Physician Inspired Shape

  May 9, 2012

   · 

  4 min read
• Deals

  Covidien plc Discloses $60 Million Purchase of Hypertension Treatment Firm

  May 9, 2012

   · 

  1 min read
• Abbott Laboratoriess New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Now Available in Canada

  May 9, 2012

   · 

  6 min read
• Drug Development

  Merck KGaA’s Erbitux Fails in Colon Cancer Study

  May 9, 2012

   · 

  1 min read
• Deals

  Activist Investor Pushes Par Pharmaceutical, Inc. to Consider Selling Itself

  May 9, 2012

   · 

  1 min read
• Drug Development

  Rock Creek Pharmaceuticals Release: Roskamp Institute Reports Beneficial Effects of Nutritional Supplementation with Anatabine in an Animal Model of Multiple Sclerosis

  May 9, 2012

   · 

  5 min read
• Job Trends

  CCS Medical Laying Off 101 on its Way Out of Town

  May 9, 2012

   · 

  1 min read
• Drug Development

  Gilead Sciences, Inc.'s Quad Pill Raises Kidney Questions, FDA Says

  May 9, 2012

   · 

  1 min read